Your Article Summary
See Latest ArticlesSerum levels of transforming growth factor-beta1 in patients with mild psoriasis vulgaris and effect of treatment with biological drugs
Clinical and Experimental Dermatology, 06/16/09
Kallimanis PG et al. - Raised TGF-beta1 levels in patients with mild PV decreased in tandem with a decrease in PASI after biological drug treatment. Hence, TGF-beta1 levels seem to be sensitive to changes in disease severity.
Related Articles
Optical coherence tomography imaging of psoriasis vulgaris: correlation with histology and disease severity
Archives of Dermatological Research, 11/17/09
Relevance Score: 67%
Urinary biomarker of oxidative stress in patients with psoriasis vulgaris and atopic dermatitis
Journal of the European Academy of Dermatology and Venereology, 11/24/09
Relevance Score: 66%
Pediatric psoriasis: an update
Therapeutics and Clinical Risk Management, 10/22/09
Relevance Score: 47%
FDA Approves New Drug to Treat Psoriasis
Internet Source, 11/02/09
Relevance Score: 46%
Study shows major burden of psoriasis
Internet Source, 10/29/09
Relevance Score: 46%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Living skin equivalents constructed using human amnions as a matrix
Journal of Dermatological Science, 12/03/09
Telomeric DNA induces p53-dependent reactive oxygen species and protects against oxidative damage
Journal of Dermatological Science, 12/03/09
Isolation of small-sized human epidermal progenitor/stem cells by Gravity Assisted Cell Sorting (GACS)
Journal of Dermatological Science, 12/03/09
Today in Psoriasis...keeping you current
Receive free subspecialty "5-minute updates" via email
Psoriasis patients generate increased serum levels of autoantibodies to tumor necrosis factor-alpha and interferon-alpha
Journal of Dermatological Science, 12/03/09
Marked Improvement in Nail Psoriasis during Treatment with Adalimumab
Dermatology, 12/01/09
The DESIRE study – psoriasis patients’ satisfaction with topical treatment using a fixed combination of calcipotriol and betamethasone dipropionate in daily clinical practice
European Journal of Dermatology, 11/30/09